ANI Pharmaceuticals, Inc. (ANIP)

USD 53.88

(-3.49%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 904.42 Million 760.08 Million 771.59 Million 461.19 Million 456.78 Million 430.6 Million
Total Current Assets 519.61 Million 344.26 Million 321.77 Million 170.32 Million 187.69 Million 152.87 Million
Cash And Short Term Investments 221.12 Million 48.22 Million 100.3 Million 7.86 Million 62.33 Million 43 Million
Cash and Cash Equivalents 221.12 Million 48.22 Million 100.3 Million 7.86 Million 62.33 Million 43 Million
Short Term Investments - - - - - -
Net Receivables 162.07 Million 165.43 Million 128.52 Million 95.79 Million 72.12 Million 64.84 Million
Inventory 111.19 Million 105.35 Million 81.69 Million 60.8 Million 48.16 Million 40.5 Million
Other Current Assets 25.22 Million 8.38 Million 11.25 Million 5.86 Million 5.07 Million 4.52 Million
Total Non-Current Assets 384.8 Million 415.82 Million 449.82 Million 290.86 Million 269.09 Million 277.72 Million
Net PPE 44.59 Million 43.24 Million 52.67 Million 41.26 Million 40.55 Million 38.09 Million
Good Will And Intangible Assets 237.23 Million 279.85 Million 322.01 Million 192.09 Million 183.96 Million 205.18 Million
Good Will 28.22 Million 28.22 Million 27.88 Million 3.58 Million 3.58 Million 3.58 Million
Intangible Assets 209 Million 251.63 Million 294.12 Million 188.51 Million 180.38 Million 201.6 Million
Long-Term Investments 6.2 Million 8.75 Million 5 Million 5 Million 5.02 Million 5.02 Million
Tax Assets 90.71 Million 81.36 Million 67.93 Million 51.7 Million 38.32 Million 27.96 Million
Other Non Current Assets 6.07 Million 2.6 Million 2.2 Million 802 Thousand 1.22 Million 1.46 Million
Other Assets - - - - - -
Total Liabilities 471.67 Million 421.54 Million 412.85 Million 265.49 Million 243.99 Million 233.34 Million
Total Current Liabilities 145.47 Million 99.43 Million 87.53 Million 78.56 Million 61.67 Million 165.54 Million
Account Payables 36.68 Million 29.3 Million 22.96 Million 11.26 Million 14.6 Million 8.88 Million
Tax Payables 8.16 Million 3.82 Million 3.66 Million 3.9 Million 1.07 Million 5.02 Million
Short Term Debt 850 Thousand 850 Thousand 850 Thousand 13.24 Million 9.94 Million 115.71 Million
Deferred Revenue 8.16 Million - 87 Thousand 80 Thousand 451 Thousand 711 Thousand
Other Current Liabilities 99.78 Million 69.28 Million 63.63 Million 53.98 Million 36.67 Million 40.23 Million
Total Non Current Liabilities 326.19 Million 322.1 Million 325.32 Million 186.92 Million 182.32 Million 67.79 Million
Long-Term Debt 309.66 Million 285.66 Million 286.52 Million 172.44 Million 175.8 Million 67.29 Million
Deferred Revenue Non Current - - -9.49 Million -7.58 Million -7.05 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 16.52 Million -44.92 Million 38.8 Million 14.48 Million 6.51 Million 496 Thousand
Other Liabilities - - - - - -
Total Equity 432.74 Million 338.54 Million 358.74 Million 195.7 Million 212.79 Million 197.26 Million
Stock Holders Equity 432.74 Million 338.54 Million 358.74 Million 195.7 Million 212.79 Million 197.26 Million
Common Stock 2000.00 1000.00 1000.00 1000.00 1000.00 1000.00
Retained Earnings -80.13 Million -97.28 Million -47.76 Million -4.97 Million 17.58 Million 11.48 Million
Accumulated other comprehensive income 8.85 Million 12.16 Million -3.05 Million -11.43 Million -4.87 Million -379 Thousand
Common Stock Equity 432.74 Million 338.54 Million 358.74 Million 195.7 Million 212.79 Million 197.26 Million
Capital Lease Obligation 4.8 Million 1.38 Million 995 Thousand 172 Thousand 292 Thousand -
Total Investments 6.2 Million 8.75 Million 5 Million 5 Million 5.02 Million 5.02 Million
Total Debt 315.32 Million 286.51 Million 287.37 Million 185.68 Million 185.74 Million 183.01 Million
Net Debt 94.2 Million 238.29 Million 187.07 Million 177.82 Million 123.41 Million 140 Million

Balance Sheet Charts